Collectively, overexpression of ERa enhanced the gemcitabine-induced autophagy and switched the autophagic cytoprotection in ER negative BCap37 cells to cytotoxicity in BCap-ER, which provided further evidence confirming that ER status could influence gemcitabine efficacy in breast cancer cells via modulating the autophagy process. Here, ESR1 is linked to breast cancer.